Abstract:One of the major applications of generative models for drug discovery targets the lead-optimization phase. During the optimization of a lead series, it is common to have scaffold constraints imposed on the structure of the molecules designed. Without enforcing such constraints, the probability of generating molecules with the required scaffold is extremely low and hinders the practicality of generative models for de novo drug design. To tackle this issue, we introduce a new algorithm, named SAMOA (Scaffold Constrained Molecular Generation), to perform scaffold-constrained in silico molecular design. We build on the well-known SMILES-based Recurrent Neural Network (RNN) generative model, with a modified sampling procedure to achieve scaffold-constrained generation. We directly benefit from the associated reinforcement learning methods, allowing to design molecules optimized for different properties while exploring only the relevant chemical space. We showcase the method's ability to perform scaffold-constrained generation on various tasks: designing novel molecules around scaffolds extracted from SureChEMBL chemical series, generating novel active molecules on the Dopamine Receptor D2 (DRD2) target, and finally, designing predicted actives on the MMP-12 series, an industrial lead-optimization project.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jcim.0c01015?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jcim.0c01015</a>.Availability of data used to train models and run experiments, algorithmic description of naive policy masking (Algorithm S1), algorithmic description of hill-climbing (Algorithm S2), examples of molecules obtained after sampling the core of fexofenadine (Figure S1 for sampled molecules, Figure S2 for the original molecule), examples of molecules obtained after replacing the ring system of fexofenadine (Figure S3), distributions of ClogP, Molecular Weight, QED and SAS for reference molecules, molecules where a branched decoration was sampled, and molecules where the core was sampled (Figure S4), the 17 validation scaffolds from SureChEMBL (Figure S5), histograms of Tanimoto similarities between generated molecules for each of the DRD2 scaffolds (Figure S6), and unicity of sampled decorations for each open positions of the DRD2 scaffolds (Figure S7) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.0c01015/suppl_file/ci0c01015_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

AIScaffold: A Web-Based Tool for Scaffold Diversification Using Deep Learning

DeepScaffold: A Comprehensive Tool for Scaffold-Based De Novo Drug Discovery Using Deep Learning

A scaffold‐based deep generative model considering molecular stereochemical information

ScaffoldGVAE: scaffold generation and hopping of drug molecules via a variational autoencoder based on multi-view graph neural networks

3D-Scaffold: A Deep Learning Framework to Generate 3D Coordinates of Drug-like Molecules with Desired Scaffolds

SMILES-based deep generative scaffold decorator for de-novo drug design

“Molecular Anatomy”: a new multi-dimensional hierarchical scaffold analysis tool

Scaffold-Constrained Molecular Generation

Scaffold-Induced Molecular Graph (SIMG): Effective Graph Sampling Methods for High-Throughput Computational Drug Discovery

Sc2Mol: a Scaffold-Based Two-Step Molecule Generator with Variational Autoencoder and Transformer.

Scaffold-based molecular design with a graph generative model

3D-SMGE: a pipeline for scaffold-based molecular generation and evaluation

Artificial Intelligent Deep Learning Molecular Generative Modeling of Scaffold-Focused and Cannabinoid CB2 Target-Specific Small-Molecule Sublibraries

Scaffold-Based Multi-Objective Drug Candidate Optimization

Scaffold-based molecular design using graph generative model

Assessing the Scaffold Diversity of Screening Libraries

Artificial Intelligence and Cheminformatics-Guided Modern Privileged Scaffold Research

Molecular generation strategy and optimization based on A2C reinforcement learning in de novo drug design

Deep Lead Optimization: Leveraging Generative AI for Structural Modification

ScaffoldGraph: an open-source library for the generation and analysis of molecular scaffold networks and scaffold trees

Learning to Extend Molecular Scaffolds with Structural Motifs